3BUX - Header Asymmetric Unit

HEADER LIGASE/SIGNALING PROTEIN 03-JAN-08 3BUX

TITLE CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS TITLE 2 BINDING MOTIF IN C-MET

COMPND MOL_ID: 1; COMPND 2 MOLECULE: 13-MERIC PEPTIDE FROM HEPATOCYTE GROWTH FACTOR COMPND 3 RECEPTOR; COMPND 4 CHAIN: A, C; COMPND 5 FRAGMENT: UNP RESIDUES 997-1009, PTYR-1003 PHOSPHOPEPTIDE; COMPND 6 SYNONYM: HGF RECEPTOR, SCATTER FACTOR RECEPTOR, SF COMPND 7 RECEPTOR, HGF/SF RECEPTOR, MET PROTO-ONCOGENE TYROSINE COMPND 8 KINASE, C-MET; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE CBL; COMPND 12 CHAIN: B, D; COMPND 13 FRAGMENT: C-CBL TKB DOMAIN, CBL N-TERMINAL, UNP RESIDUES COMPND 14 23-351; COMPND 15 SYNONYM: SIGNAL TRANSDUCTION PROTEIN CBL, PROTO-ONCOGENE C- COMPND 16 CBL, CASITAS B-LINEAGE LYMPHOMA PROTO-ONCOGENE, RING COMPND 17 FINGER PROTEIN 55; COMPND 18 EC: 6.3.2.-; COMPND 19 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: SYNTHETIC CONSTRUCT; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 6 ORGANISM_COMMON: HUMAN; SOURCE 7 ORGANISM_TAXID: 9606; SOURCE 8 GENE: CBL, CBL2, RNF55; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: ROSETTA; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PGEX4T1

KEYWDS CBL, TKB, LIGASE, SIGNAL TRANSDUCTION, PROTO-ONCOGENE, KEYWDS 2 COMPLEX, ATP-BINDING, GLYCOPROTEIN, KINASE, MEMBRANE, KEYWDS 3 NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSFERASE, KEYWDS 4 TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, CALCIUM, CYTOPLASM, KEYWDS 5 METAL-BINDING, SH2 DOMAIN, UBL CONJUGATION PATHWAY, ZINC, KEYWDS 6 ZINC-FINGER, LIGASE/SIGNALING PROTEIN COMPLEX

EXPDTA X-RAY DIFFRACTION

AUTHOR C.NG,R.A.JACKSON,J.P.BUSCHDORF,Q.SUN,G.R.GUY,J.SIVARAMAN

REVDAT 3 24-FEB-09 3BUX 1 VERSN REVDAT 2 18-MAR-08 3BUX 1 JRNL REMARK REVDAT 1 26-FEB-08 3BUX 0

JRNL AUTH C.NG,R.A.JACKSON,J.P.BUSCHDORF,Q.SUN,G.R.GUY, JRNL AUTH 2 J.SIVARAMAN JRNL TITL STRUCTURAL BASIS FOR A NOVEL INTRAPEPTIDYL H-BOND JRNL TITL 2 AND REVERSE BINDING OF C-CBL-TKB DOMAIN SUBSTRATES JRNL REF EMBO J. V. 27 804 2008 JRNL REFN ISSN 0261-4189 JRNL PMID 18273061 JRNL DOI 10.1038/EMBOJ.2008.18

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 11808.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.0 REMARK 3 NUMBER OF REFLECTIONS : 130160 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.500 REMARK 3 FREE R VALUE TEST SET COUNT : 2208 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5134 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 686 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.01100 REMARK 3 B22 (A**2) : 1.43800 REMARK 3 B33 (A**2) : 1.57300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.73300 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 52.38 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : PTR.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 3BUX COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-JAN-08. REMARK 100 THE RCSB ID CODE IS RCSB045986.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 142289 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.23600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2CBL REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.15M MALIC ACID, 20% PEG 3350, PH REMARK 280 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 52.40000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 997 REMARK 465 THR A 1006 REMARK 465 PHE A 1007 REMARK 465 PRO A 1008 REMARK 465 GLU A 1009 REMARK 465 GLY B 23 REMARK 465 SER B 24 REMARK 465 LEU B 25 REMARK 465 ILE B 26 REMARK 465 GLY B 27 REMARK 465 LEU B 28 REMARK 465 MET B 29 REMARK 465 LYS B 30 REMARK 465 ASP B 31 REMARK 465 ALA B 32 REMARK 465 PHE B 33 REMARK 465 GLN B 34 REMARK 465 PRO B 35 REMARK 465 HIS B 36 REMARK 465 HIS B 37 REMARK 465 HIS B 38 REMARK 465 HIS B 39 REMARK 465 HIS B 40 REMARK 465 HIS B 41 REMARK 465 HIS B 42 REMARK 465 LEU B 43 REMARK 465 SER B 44 REMARK 465 PRO B 45 REMARK 465 HIS B 46 REMARK 465 SER C 997 REMARK 465 THR C 1006 REMARK 465 PHE C 1007 REMARK 465 PRO C 1008 REMARK 465 GLU C 1009 REMARK 465 GLY D 23 REMARK 465 SER D 24 REMARK 465 LEU D 25 REMARK 465 ILE D 26 REMARK 465 GLY D 27 REMARK 465 LEU D 28 REMARK 465 MET D 29 REMARK 465 LYS D 30 REMARK 465 ASP D 31 REMARK 465 ALA D 32 REMARK 465 PHE D 33 REMARK 465 GLN D 34 REMARK 465 PRO D 35 REMARK 465 HIS D 36 REMARK 465 HIS D 37 REMARK 465 HIS D 38 REMARK 465 HIS D 39 REMARK 465 HIS D 40 REMARK 465 HIS D 41 REMARK 465 HIS D 42 REMARK 465 LEU D 43 REMARK 465 SER D 44 REMARK 465 PRO D 45 REMARK 465 HIS D 46

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 999 -8.64 -44.38 REMARK 500 ASN B 79 74.39 -69.87 REMARK 500 LYS B 105 38.65 -83.24 REMARK 500 LYS B 137 -124.44 50.29 REMARK 500 ASN B 144 -4.68 77.81 REMARK 500 PHE B 169 59.47 -119.22 REMARK 500 ALA B 262 -50.57 -135.14 REMARK 500 ALA B 270 -111.47 -36.79 REMARK 500 TYR B 337 79.38 -115.59 REMARK 500 GLU C 999 -13.83 -42.65 REMARK 500 LYS D 105 41.09 -84.41 REMARK 500 LYS D 137 -129.17 48.29 REMARK 500 ASN D 144 -5.24 78.19 REMARK 500 PHE D 169 59.40 -117.40 REMARK 500 ALA D 262 -50.58 -135.64 REMARK 500 ALA D 270 -113.78 -36.83 REMARK 500 TYR D 337 78.19 -114.90 REMARK 500 REMARK 500 REMARK: NULL

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3BUM RELATED DB: PDB REMARK 900 C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN REMARK 900 SPROUTY2 REMARK 900 RELATED ID: 3BUN RELATED DB: PDB REMARK 900 C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN REMARK 900 SPROUTY4 REMARK 900 RELATED ID: 3BUO RELATED DB: PDB REMARK 900 C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN EGF REMARK 900 RECEPTOR REMARK 900 RELATED ID: 3BUW RELATED DB: PDB REMARK 900 C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN SYK

DBREF 3BUX A 997 1009 UNP P08581 MET_HUMAN 997 1009 DBREF 3BUX B 23 351 UNP P22681 CBL_HUMAN 23 351 DBREF 3BUX C 997 1009 UNP P08581 MET_HUMAN 997 1009 DBREF 3BUX D 23 351 UNP P22681 CBL_HUMAN 23 351

SEQADV 3BUX SER B 24 UNP P22681 GLY 24 CLONING ARTIFACT SEQADV 3BUX SER D 24 UNP P22681 GLY 24 CLONING ARTIFACT

SEQRES 1 A 13 SER ASN GLU SER VAL ASP PTR ARG ALA THR PHE PRO GLU SEQRES 1 B 329 GLY SER LEU ILE GLY LEU MET LYS ASP ALA PHE GLN PRO SEQRES 2 B 329 HIS HIS HIS HIS HIS HIS HIS LEU SER PRO HIS PRO PRO SEQRES 3 B 329 GLY THR VAL ASP LYS LYS MET VAL GLU LYS CYS TRP LYS SEQRES 4 B 329 LEU MET ASP LYS VAL VAL ARG LEU CYS GLN ASN PRO LYS SEQRES 5 B 329 LEU ALA LEU LYS ASN SER PRO PRO TYR ILE LEU ASP LEU SEQRES 6 B 329 LEU PRO ASP THR TYR GLN HIS LEU ARG THR ILE LEU SER SEQRES 7 B 329 ARG TYR GLU GLY LYS MET GLU THR LEU GLY GLU ASN GLU SEQRES 8 B 329 TYR PHE ARG VAL PHE MET GLU ASN LEU MET LYS LYS THR SEQRES 9 B 329 LYS GLN THR ILE SER LEU PHE LYS GLU GLY LYS GLU ARG SEQRES 10 B 329 MET TYR GLU GLU ASN SER GLN PRO ARG ARG ASN LEU THR SEQRES 11 B 329 LYS LEU SER LEU ILE PHE SER HIS MET LEU ALA GLU LEU SEQRES 12 B 329 LYS GLY ILE PHE PRO SER GLY LEU PHE GLN GLY ASP THR SEQRES 13 B 329 PHE ARG ILE THR LYS ALA ASP ALA ALA GLU PHE TRP ARG SEQRES 14 B 329 LYS ALA PHE GLY GLU LYS THR ILE VAL PRO TRP LYS SER SEQRES 15 B 329 PHE ARG GLN ALA LEU HIS GLU VAL HIS PRO ILE SER SER SEQRES 16 B 329 GLY LEU GLU ALA MET ALA LEU LYS SER THR ILE ASP LEU SEQRES 17 B 329 THR CYS ASN ASP TYR ILE SER VAL PHE GLU PHE ASP ILE SEQRES 18 B 329 PHE THR ARG LEU PHE GLN PRO TRP SER SER LEU LEU ARG SEQRES 19 B 329 ASN TRP ASN SER LEU ALA VAL THR HIS PRO GLY TYR MET SEQRES 20 B 329 ALA PHE LEU THR TYR ASP GLU VAL LYS ALA ARG LEU GLN SEQRES 21 B 329 LYS PHE ILE HIS LYS PRO GLY SER TYR ILE PHE ARG LEU SEQRES 22 B 329 SER CYS THR ARG LEU GLY GLN TRP ALA ILE GLY TYR VAL SEQRES 23 B 329 THR ALA ASP GLY ASN ILE LEU GLN THR ILE PRO HIS ASN SEQRES 24 B 329 LYS PRO LEU PHE GLN ALA LEU ILE ASP GLY PHE ARG GLU SEQRES 25 B 329 GLY PHE TYR LEU PHE PRO ASP GLY ARG ASN GLN ASN PRO SEQRES 26 B 329 ASP LEU THR GLY SEQRES 1 C 13 SER ASN GLU SER VAL ASP PTR ARG ALA THR PHE PRO GLU SEQRES 1 D 329 GLY SER LEU ILE GLY LEU MET LYS ASP ALA PHE GLN PRO SEQRES 2 D 329 HIS HIS HIS HIS HIS HIS HIS LEU SER PRO HIS PRO PRO SEQRES 3 D 329 GLY THR VAL ASP LYS LYS MET VAL GLU LYS CYS TRP LYS SEQRES 4 D 329 LEU MET ASP LYS VAL VAL ARG LEU CYS GLN ASN PRO LYS SEQRES 5 D 329 LEU ALA LEU LYS ASN SER PRO PRO TYR ILE LEU ASP LEU SEQRES 6 D 329 LEU PRO ASP THR TYR GLN HIS LEU ARG THR ILE LEU SER SEQRES 7 D 329 ARG TYR GLU GLY LYS MET GLU THR LEU GLY GLU ASN GLU SEQRES 8 D 329 TYR PHE ARG VAL PHE MET GLU ASN LEU MET LYS LYS THR SEQRES 9 D 329 LYS GLN THR ILE SER LEU PHE LYS GLU GLY LYS GLU ARG SEQRES 10 D 329 MET TYR GLU GLU ASN SER GLN PRO ARG ARG ASN LEU THR SEQRES 11 D 329 LYS LEU SER LEU ILE PHE SER HIS MET LEU ALA GLU LEU SEQRES 12 D 329 LYS GLY ILE PHE PRO SER GLY LEU PHE GLN GLY ASP THR SEQRES 13 D 329 PHE ARG ILE THR LYS ALA ASP ALA ALA GLU PHE TRP ARG SEQRES 14 D 329 LYS ALA PHE GLY GLU LYS THR ILE VAL PRO TRP LYS SER SEQRES 15 D 329 PHE ARG GLN ALA LEU HIS GLU VAL HIS PRO ILE SER SER SEQRES 16 D 329 GLY LEU GLU ALA MET ALA LEU LYS SER THR ILE ASP LEU SEQRES 17 D 329 THR CYS ASN ASP TYR ILE SER VAL PHE GLU PHE ASP ILE SEQRES 18 D 329 PHE THR ARG LEU PHE GLN PRO TRP SER SER LEU LEU ARG SEQRES 19 D 329 ASN TRP ASN SER LEU ALA VAL THR HIS PRO GLY TYR MET SEQRES 20 D 329 ALA PHE LEU THR TYR ASP GLU VAL LYS ALA ARG LEU GLN SEQRES 21 D 329 LYS PHE ILE HIS LYS PRO GLY SER TYR ILE PHE ARG LEU SEQRES 22 D 329 SER CYS THR ARG LEU GLY GLN TRP ALA ILE GLY TYR VAL SEQRES 23 D 329 THR ALA ASP GLY ASN ILE LEU GLN THR ILE PRO HIS ASN SEQRES 24 D 329 LYS PRO LEU PHE GLN ALA LEU ILE ASP GLY PHE ARG GLU SEQRES 25 D 329 GLY PHE TYR LEU PHE PRO ASP GLY ARG ASN GLN ASN PRO SEQRES 26 D 329 ASP LEU THR GLY

MODRES 3BUX PTR A 1003 TYR O-PHOSPHOTYROSINE MODRES 3BUX PTR C 1003 TYR O-PHOSPHOTYROSINE

HET PTR A1003 16 HET PTR C1003 16

HETNAM PTR O-PHOSPHOTYROSINE

HETSYN PTR PHOSPHONOTYROSINE

FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 5 HOH *686(H2 O)

HELIX 1 1 ASP B 52 GLN B 71 1 20 HELIX 2 2 ASN B 72 ALA B 76 5 5 HELIX 3 3 TYR B 83 TYR B 102 1 20 HELIX 4 4 LYS B 105 ASN B 112 1 8 HELIX 5 5 ASN B 112 LYS B 137 1 26 HELIX 6 6 GLU B 138 GLU B 142 5 5 HELIX 7 7 SER B 145 PHE B 169 1 25 HELIX 8 8 PRO B 170 LEU B 173 5 4 HELIX 9 9 GLN B 175 PHE B 179 5 5 HELIX 10 10 LYS B 183 GLY B 195 1 13 HELIX 11 11 TRP B 202 HIS B 213 1 12 HELIX 12 12 SER B 217 ASP B 229 1 13 HELIX 13 13 VAL B 238 PHE B 248 1 11 HELIX 14 14 PRO B 250 SER B 252 5 3 HELIX 15 15 SER B 253 ALA B 262 1 10 HELIX 16 16 THR B 273 GLN B 282 1 10 HELIX 17 17 LYS B 283 ILE B 285 5 3 HELIX 18 18 PRO B 323 GLU B 334 1 12 HELIX 19 19 ASP D 52 GLN D 71 1 20 HELIX 20 20 ASN D 72 ALA D 76 5 5 HELIX 21 21 TYR D 83 TYR D 102 1 20 HELIX 22 22 LYS D 105 ASN D 112 1 8 HELIX 23 23 ASN D 112 LYS D 137 1 26 HELIX 24 24 GLU D 138 GLU D 142 5 5 HELIX 25 25 SER D 145 PHE D 169 1 25 HELIX 26 26 PRO D 170 LEU D 173 5 4 HELIX 27 27 GLN D 175 PHE D 179 5 5 HELIX 28 28 LYS D 183 GLY D 195 1 13 HELIX 29 29 TRP D 202 HIS D 213 1 12 HELIX 30 30 SER D 217 ASP D 229 1 13 HELIX 31 31 VAL D 238 PHE D 248 1 11 HELIX 32 32 PRO D 250 SER D 252 5 3 HELIX 33 33 SER D 253 ALA D 262 1 10 HELIX 34 34 THR D 273 GLN D 282 1 10 HELIX 35 35 LYS D 283 ILE D 285 5 3 HELIX 36 36 PRO D 323 GLU D 334 1 12

SHEET 1 A 2 ILE B 199 PRO B 201 0 SHEET 2 A 2 TYR B 235 SER B 237 -1 O ILE B 236 N VAL B 200 SHEET 1 B 4 ILE B 314 THR B 317 0 SHEET 2 B 4 TRP B 303 VAL B 308 -1 N ILE B 305 O THR B 317 SHEET 3 B 4 SER B 290 LEU B 295 -1 N ARG B 294 O ALA B 304 SHEET 4 B 4 PHE B 339 PRO B 340 1 O PHE B 339 N TYR B 291 SHEET 1 C 2 ILE D 199 PRO D 201 0 SHEET 2 C 2 TYR D 235 SER D 237 -1 O ILE D 236 N VAL D 200 SHEET 1 D 4 ILE D 314 THR D 317 0 SHEET 2 D 4 TRP D 303 VAL D 308 -1 N ILE D 305 O THR D 317 SHEET 3 D 4 SER D 290 LEU D 295 -1 N ARG D 294 O ALA D 304 SHEET 4 D 4 PHE D 339 PRO D 340 1 O PHE D 339 N TYR D 291

LINK C ASP A1002 N PTR A1003 1555 1555 1.33 LINK C PTR A1003 N ARG A1004 1555 1555 1.33 LINK C ASP C1002 N PTR C1003 1555 1555 1.33 LINK C PTR C1003 N ARG C1004 1555 1555 1.33

CISPEP 1 PRO B 81 PRO B 82 0 -0.19 CISPEP 2 GLN B 249 PRO B 250 0 1.31 CISPEP 3 PRO D 81 PRO D 82 0 -0.07 CISPEP 4 GLN D 249 PRO D 250 0 0.74

CRYST1 63.175 104.800 52.598 90.00 90.41 90.00 P 1 21 1 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.015829 0.000000 0.000113 0.00000

SCALE2 0.000000 0.009542 0.000000 0.00000

SCALE3 0.000000 0.000000 0.019013 0.00000